Condition: Aortic Stenosis · Ascending Aortic Dilatation · Bicuspid Aortic Valve · Sponsor: China National Center for Cardiovascular Diseases
The goal of this observational study is to assess the changes of ascending aortic diameter in patients undergoing transcatheter aortic valve replacement. The main questions it aims to answer are: 1. whether the ascending aortic diameter increases or remains stable after transcatheter aortic valve replacement, especially in patients with preoperative ascending aortic dilatation; 2. the determinants of postoperative ascending aortic dilatation.
This description comes directly from the study's public registry record.
Xiangbin Pan, Dr · 0086-010-88396666 · panxiangbin@fuwaihospital.org
Kang An, Dr · 0086-15801301740 · ankang913@126.com
Always discuss trial participation with your own doctor first.
| National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05739253